- Home
- BZH vs RLAY Comparison
BZH vs RLAY Comparison
Compare BZH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- RLAY
- Stock Information
- Founded
- BZH 1985
- RLAY 2015
- Country
- BZH United States
- RLAY United States
- Employees
- BZH N/A
- RLAY N/A
- Industry
- BZH Homebuilding
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZH Consumer Discretionary
- RLAY Health Care
- Exchange
- BZH Nasdaq
- RLAY Nasdaq
- Market Cap
- BZH 989.6M
- RLAY 1.1B
- IPO Year
- BZH 1994
- RLAY 2020
- Fundamental
- Price
- BZH $35.07
- RLAY $4.75
- Analyst Decision
- BZH Strong Buy
- RLAY Strong Buy
- Analyst Count
- BZH 3
- RLAY 9
- Target Price
- BZH $39.67
- RLAY $20.88
- AVG Volume (30 Days)
- BZH 363.3K
- RLAY 1.5M
- Earning Date
- BZH 11-13-2024
- RLAY 11-06-2024
- Dividend Yield
- BZH N/A
- RLAY N/A
- EPS Growth
- BZH N/A
- RLAY N/A
- EPS
- BZH 4.53
- RLAY N/A
- Revenue
- BZH $2,330,197,000.00
- RLAY $10,006,000.00
- Revenue This Year
- BZH $20.29
- RLAY N/A
- Revenue Next Year
- BZH $14.20
- RLAY N/A
- P/E Ratio
- BZH $7.76
- RLAY N/A
- Revenue Growth
- BZH 5.59
- RLAY N/A
- 52 Week Low
- BZH $25.48
- RLAY $4.48
- 52 Week High
- BZH $38.22
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- BZH 62.19
- RLAY 30.59
- Support Level
- BZH $32.21
- RLAY $4.60
- Resistance Level
- BZH $36.72
- RLAY $5.03
- Average True Range (ATR)
- BZH 1.19
- RLAY 0.29
- MACD
- BZH 0.30
- RLAY -0.04
- Stochastic Oscillator
- BZH 60.35
- RLAY 16.23
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).